Portal de Periódicos da CAPES

Acute Otitis Media in the 1990s: The Impact of Antibiotic Resistance

1998; Elsevier BV; Volume: 27; Issue: 2 Linguagem: Inglês

10.3928/0090-4481-19980201-06

1938-2359

Stephen A. Chartrand, Annpey Pong,

Streptococcal Infections and Treatments

Acute Otitis Media in the 1990s: The Impact of Antibiotic Resistance Stephen A Chartrand, MD, , and , MD Alice Pong, MD, , MD Stephen A Chartrand, MD and Alice Pong, MD Pediatric Annals, 2013;27(2):86–95Published Online:February 01, 1998https://doi.org/10.3928/0090-4481-19980201-06Cited by:12View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. McCraig LF. Hughes JM. Trends in antimicrobial drug prescribing among officebased physicians in the United Stales. JAMA. 1995;273:214-219. Google Scholar2 Marchant CD, Cailin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents fot acute otitis media: the "Pollyantia phenomenon." J Pediatr.1992;120:72-77. Google Scholar3. Klein JO. Teele DW. Pelton Sl. New concepts in otitis media: results of investigations of the greater Boston otitis media study group. Adii Pedina. 1992:39:127-156. Google Scholar4. Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin infect is. 1992;15(Suppl i):S62-88. Google Scholar5. Klein JO, Teele DW. Isolation of viruses and mycoplasmas from middle ear effusions; a review. Ann Otol Rhinol Laryngol. 1976;85(2 Suppl 25 pt 2):140-144. Google Scholar6. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994:264:382-388. Google Scholar7. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Super DM, RehmusJM. Host factors and early therapeutic response in acute otitis media. J Pediatr. 1991;118:178-183. Google Scholar8. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macro! ides but sensitive ro clindamycin a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 1996;40:1817-1824. Google Scholar9. National Committee for Clinical Laboratory Standards. Performance Standards far Antimicrobial Susceptibility Testing; eighth informational supplement. M100-S8, vol. 18. Wayne, PA: National Committee for Clinical Laboratory Standards; 1998. Google Scholar10. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae an overview. Clin Infect Dis 1992:15:77-83. Google Scholar11. Friedland IR1 McCracken CH. Management of infection caused by antibiotic- resistane Streptococcus pneumoniae. N Engl J Med. 1994:331:377-382. Google Scholar12. Block SL, Harrison CJ, Hedrick JA, Tyler RD, Smith RA, Keegan E, Chartrand SA. Penicillin resistant Streptococcus pneumonias in acute otiti; media; risk factors, susceptibility patterns, and antimicrobial management. Pedian Infect Dis J. 1995:14-751-759. Google Scholar13. Boken DJ, Chartrand SA, Goering RV, Krüger R. Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center Pediatr Infect Dis J. 1995;14:879-884. Google Scholar14. Dowell SF, Jayaraman M, Keyserling H, Kokzak M, Schwanz B. Currrent antimicrobial use fot pediatrie upper respiratory infections. In: Program and Abj tracts of the Infectious Disease Society of America 35t/i Annual Meeting, San Francisco, September 13-16, 1997. (poster 377). Google Scholar15. Reichlet MR, Allphin AA, Breiman RF, Schreiber JR. Arnold JE. McDougal LK, Facklam RR, Boierbaum B. Walton RO, et al. The spread of multiply resistant Streptococcus pneumoruoi at a day care center in Ohio. J infect Dis. 1992;166:13461353. Google Scholar16. Doem GV. Resistance among problem respiratory pathogens in pediatrics. Pediatr infect Dis J. 1995:14:420-423 Google Scholar17. Brook I, Gober AE. Monthly changes in the rateof recovery of penicillin-resistant organisms from children. Pediarr Infect Dis J. 1997;16:255-257. Google Scholar18. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfasoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis. 1996;22:143-145. Google Scholar19. Herman S, Roark R. Factors influencing outcome in children treated with antibiotics for acute otitis media. Pediacr Infect Dis J. 1993;12:20-24. Google Scholar20. Doem GV, Brueggemann AB, Pierce G, Hogan T, Holley Jr. HP. Rauch A. Prevalence of antimicrobial resistance among 7Z3 outpatient clinical isolates of Moraxella calormaU! in the United Slates in 1994 and 1995: results of a 30-cemrr national surveillance study. Antimicrob Agents Chemower. 1996;40:2884-2886. Google Scholar21. Rosenfey RM, Vertrees JE, Cart J, Cipolle RJ, Uden DL, Giebink GS, Canafax DM. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomiied trials. J Pediatro. 1994;124:355-367. Google Scholar22. Klein JO. Microbiologie efficacy of antibacterial drugs for acute ontis media. Pediotr Infect Dis J. 1993;2:973-975. Google Scholar23. Kaleida PH, Cassclbrani ML. Rockette HE. et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87:466-474. Google Scholar24. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media; principles of judicious use of antimicrobial agents. Pediatrics. 1998; 101 (suppl): 165-171. Google Scholar25. Craig WA, Andes D. Pharmacokmetici and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:Z55-Z59. Google Scholar26. Craig WA. Interrelationship between pharrnacokinetics and pharmacodynamics in determining dosage regimens fot broad -spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995;22:89-96. Google Scholar27. Harrison CJ. Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy. Pediarr Infect Dis J. 1997;16(suppl2):S12-S16. Google Scholar28. Klein JO. Antibiotic therapy for acute otitis media (AOM): is amoxicillm still the drug of choice? Rep Pediarr Infect Dis. 1991;1:1-2. Google Scholar29. Harrison CJ, Marks Ml, Welch DF. Microbiology of recently treated otitis media compared to previously untreated purulent otitis media. Pediarr Infect Dis. 1985:4:641-646. Google Scholar30. Bodor FF. Conjunctivitis-otit is syndrome. Pediatrici. 1982;69:695-698. Google Scholar31. Thomson KS. Chartrand SA, Sanders CC, Block SL. Trovafloxacin, a new fluroqmnoione with potent activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 1997;41:478-480. Google Scholar32. Hanison CJ, Chartrand SA, Pichichero ME, Microbiologie and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acure otitis media in infants and children. Pediarr Inject Dis J. 1993; 12:62-69. Google Scholar33. Dagan R, Yagupsky P. Hiss DM, Leiberman A, Leibovitz E. Bactériologie response in acute otitis media (AOM): comparison between aiithromycin (AZ), cefaclot (CEC), and amoxacillin (AMOX). In: Abstracts of the 37th Interscience Conference on AntimrcroEial Agents and Chemotherapy, September, Toronto, 1997 (abstract K-103). Google Scholar34. Dagan R, Abramson O, Leiboviti E, Greenberg D, Lang R. Goshen S. Yagupsly R Leiberman A, Fliss DM. Bactériologie response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis. 1997; 176: 1253-1259. Google Scholar35. Shyu WC, Haddad J, Reilly J, Khan WN, Campbell DA, Tsai Y. Barbhaiya RH. Penetration of celprozil into middle ear fluid of patients with otitis media. Antimicrob Agents Chemother. 1994;38:2210-2212. Google Scholar36. Pichichero ME. McLinn S. Aronovin G, fiddes R, Blumer J, Nelson K, Dashefesky B. Cefprozil treatment of persistent and recurrent acute otitis media. Pediatr Infect Dis J. 1997;16:471-478. Google Scholar37. Neu HC. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin. cefljtime. Pediarr Infect Dis J. 1987;6:958-962. Google Scholar38. Harrison CJ, Chanrand SA. Rodríguez W Schwara R. Pollaci J, Thedinget B, Block SL, Hedrick JA. Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion. Pediatr infect Dis J. 1997; 16:816-817. Google Scholar39. Kumiesi H, Sheiton S. Brown O, Manning S, Nelson JD. Loracarbef concentrations in middle ear fluid. Anomicrob Agents Cnemotner. 1990:34:2030-2031. Google Scholar40. Barry AL, Fuchs PC, Brown SD. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Cnemother. 1997;40:139-140. Google Scholar41. McCarty JM. Bacterial susceptibility and tympanocentesis in acute otitis media. Pediatr Infect Dis J. 1995;14:S45-S50. Google Scholar42. Howie VM. Eradication of bacterial pathogens from middle ear infections. CIm Infect Dis. 1992;14(Suppl2):209-210. Google Scholar43. Boken DJ, Chartrand SA, Smilh-Moland E, Goering RV. Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centers. Pediatr Infect Dis J. 1996; 15:667-672. Google Scholar44. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneimumiae. Pediatr Infect Dis J. 1996; 15:932-939. Google Scholar45. Gudnason TH. Sigurdardottir LY, Kristinsson KG, Kristjansson K, Laxdal TH, One dose ceftriaxone treatment of otitis media caused by multi-resistant pneumococci. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. New Orleans, September, 1996 (abstract LM24). Google Scholar46. Blumer J. Presented at ceftriaxone workshop on acute otitis media. New York, NY, January, 1998. Google Scholar47. Seikel K, Sheiton S, McCracken GH, Middle Ear Fluid Concentrations of Amoxicillin after Large Dosages in Children with Acute Otitis Media. Pediatric Infectious Disease Journal, July 1997; 16(7):7 10-711. Google Scholar48. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media- principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(suppl): 165-171. Google Scholar49. Giebink GS, Meiet JD, Quartey MK, Liebelet CL, Le CT. Immunogenicity and efficacy of Strrpiococciu pneumoniae polysaccharide-prolein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model. J Infect Dis. 1996;173:119-127. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Komatsu K, Nam D, Lee J, Yoneda G, Yan C and Li J (2020) Vinpocetine Suppresses Streptococcus pneumoniae –Induced Inflammation via Inhibition of ERK1 by CYLD , The Journal of Immunology, 10.4049/jimmunol.1901299, 204:4, (933-942), Online publication date: 15-Feb-2020. Wang W, Komatsu K, Huang Y, Wu J, Zhang W, Lee J, Miyata M, Xu H, Li J and Sun J (2014) CYLD Negatively Regulates Nontypeable Haemophilus influenzae-Induced IL-8 Expression via Phosphatase MKP-1-Dependent Inhibition of ERK, PLoS ONE, 10.1371/journal.pone.0112516, 9:11, (e112516) Wang W, Hyang Lim J and Li J (2012) Synergistic and feedback signaling mechanisms in the regulation of inflammation in respiratory infections, Cellular & Molecular Immunology, 10.1038/cmi.2011.65, 9:2, (131-135), Online publication date: 1-Mar-2012. Oğuz F, Ünüvar E, Süoğlu Y, Erdamar B, Dündar G, Katircioğlu S and Sıdal M (2003) Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs. 3 days azitromycin, International Journal of Pediatric Otorhinolaryngology, 10.1016/S0165-5876(02)00360-9, 67:1, (43-51), Online publication date: 1-Jan-2003. Bakaletz L (2014) Otitis Media Polymicrobial Diseases, 10.1128/9781555817947.ch14, (259-298) Fendrick A, Saint S, Brook I, Jacobs M, Pelton S and Sethi S (2001) Diagnosis and treatment of upper respiratory tract infections in the primary care setting, Clinical Therapeutics, 10.1016/S0149-2918(01)80137-5, 23:10, (1683-1706), Online publication date: 1-Oct-2001. Zhanel G, Dueck M, Hoban D, Vercaigne L, Embil J, Gin A and Karlowsky J (2001) Review of Macrolides and Ketolides, Drugs, 10.2165/00003495-200161040-00003, 61:4, (443-498), . Erramouspe J and Heyneman C (2016) Treatment and Prevention of Otitis Media, Annals of Pharmacotherapy, 10.1345/aph.19391, 34:12, (1452-1468), Online publication date: 1-Dec-2000. Mudry A (1999) Controverses autour de l'otite moyenne aiguë, Archives de Pédiatrie, 10.1016/S0929-693X(00)88899-5, 6:12, (1338-1344), Online publication date: 1-Dec-1999. Bennett J and St. Geme J (1999) BACTERIAL RESISTANCE AND ANTIBIOTIC USE IN THE EMERGENCY DEPARTMENT, Pediatric Clinics of North America, 10.1016/S0031-3955(05)70178-4, 46:6, (1125-1143), Online publication date: 1-Dec-1999. Leggiadro R (1998) Antibiotic therapy for otitis media, Seminars in Pediatric Infectious Diseases, 10.1016/S1045-1870(98)80020-4, 9:4, (310-313), Online publication date: 1-Oct-1998. Bauchner H and Philipp B (1998) Reducing Inappropriate Oral Antibiotic Use: A Prescription for Change, Pediatrics, 10.1542/peds.102.1.142, 102:1, (142-144), Online publication date: 1-Jul-1998. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 19.3 MB Published online2/01/98